Overview

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

Status:
Unknown status
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The major objective of this study is to evaluate the therapeutic effect of a topical treatment simultaneously inhibiting Dipeptidyl Peptidase IV and Aminopeptidase N (IMTM #IP10.C8) in patients with mild to moderate psoriasis of the skin
Phase:
Phase 2
Details
Lead Sponsor:
Immune Technologies & Medicine GmbH